Low Vitamin D Symptoms: When to See a Doctor

What Does Low Vitamin D Actually Feel Like?

Vitamin D deficiency rarely announces itself with a single dramatic symptom. Instead, it produces a cluster of vague complaints that patients often attribute to aging, stress, or poor sleep. The most frequently reported signs include persistent fatigue that does not improve with rest, aching bones (especially in the lower back, hips, and legs), proximal muscle weakness making it harder to climb stairs or rise from a chair, and a low mood that may mimic mild depression.

A 2020 cross-sectional analysis of 25,871 participants in the National Health and Nutrition Examination Survey (NHANES) found that individuals with serum 25(OH)D levels below 20 ng/mL reported significantly higher fatigue scores compared to those with levels above 30 ng/mL 1. That association held after adjusting for age, BMI, physical activity, and sleep duration.

Muscle symptoms deserve special attention. Vitamin D receptors are expressed in skeletal muscle tissue, and deficiency impairs calcium handling within muscle fibers. A meta-analysis of 30 randomized controlled trials (N=5,615) published in the Journal of the American Medical Association demonstrated that vitamin D supplementation improved both upper and lower extremity muscle strength in adults with baseline levels below 12 ng/mL 2. The effect was modest but clinically meaningful, particularly in older adults at fall risk.

Frequent respiratory infections may also signal deficiency. A Cochrane systematic review of 46 RCTs (N=75,541) concluded that daily or weekly vitamin D supplementation reduced acute respiratory tract infections by 12% overall, with the strongest protective effect (42% reduction) seen in participants whose baseline 25(OH)D was below 10 ng/mL 3.

Some symptoms overlap with thyroid disorders, iron-deficiency anemia, and depression. That overlap is precisely why lab confirmation matters.

Why You Might Be Deficient

The body synthesizes vitamin D3 (cholecalciferol) when UVB radiation strikes 7-dehydrocholesterol in the skin. Any factor that limits UVB exposure or interferes with absorption and metabolism can drive levels down.

Sunlight and geography. People living above 37°N latitude (roughly a line from San Francisco to Richmond, Virginia) produce little to no cutaneous vitamin D from November through February because the solar zenith angle filters out UVB wavelengths 4. Year-round sunscreen use with SPF 30 reduces vitamin D synthesis by more than 95%.

Skin pigmentation. Melanin competes with 7-dehydrocholesterol for UVB photons. Black Americans have a deficiency prevalence of roughly 76%, compared to 40% among Hispanic Americans and 18% among White Americans, based on NHANES 2001-2006 data 5.

Obesity. Vitamin D is fat-soluble. Adipose tissue sequesters circulating 25(OH)D, reducing its bioavailability. A BMI above 30 kg/m² approximately doubles the risk of deficiency compared to normal weight, a relationship documented in a pooled analysis of 21 cohort studies (N=42,024) 6.

Malabsorption syndromes. Celiac disease, Crohn's disease, chronic pancreatitis, and prior bariatric surgery all reduce intestinal absorption of fat-soluble vitamins. Patients who have undergone Roux-en-Y gastric bypass require lifelong monitoring and often need doses two to three times higher than standard recommendations 7.

Medications. Glucocorticoids accelerate vitamin D catabolism. Anticonvulsants such as phenytoin and carbamazepine induce hepatic CYP enzymes that inactivate 25(OH)D. Cholestyramine and orlistat impair fat absorption and, with it, vitamin D uptake.

Age. Adults over 65 produce approximately 25% of the cutaneous vitamin D that a 20-year-old generates from the same UVB dose, because 7-dehydrocholesterol levels in the skin decline with age 8.

When to See a Doctor: Red and Yellow Flags

Not every person with mild fatigue or a dip in mood needs to rush to a clinic. But certain scenarios should prompt a medical evaluation without delay.

Red flags (seek care within days):

• Unexplained fracture from minimal trauma (a fall from standing height or less). This may indicate osteomalacia, the adult manifestation of severe vitamin D deficiency that softens bone.
• Severe proximal muscle weakness that interferes with walking, rising from a seated position, or maintaining balance.
• Tetany, muscle spasms, or perioral tingling suggesting hypocalcemia secondary to profoundly low vitamin D.
• A child with bowed legs, delayed fontanelle closure, or widened wrists. These are classic signs of rickets.

Yellow flags (schedule an appointment within one to two weeks):

• Persistent fatigue lasting more than three weeks without another clear explanation.
• Recurrent infections (three or more respiratory infections in a single winter season).
• Bone or muscle aches that progressively worsen over weeks.
• Known risk factors (dark skin, BMI above 30, malabsorption disorder, limited outdoor time) combined with any symptom above.

Dr. Michael Holick, professor of medicine at Boston University and author of the Endocrine Society's 2011 clinical practice guideline on vitamin D, has stated: "Vitamin D deficiency is the most common nutritional deficiency worldwide and should be screened for in all patients at risk, not just those presenting with bone disease" 9.

The U.S. Preventive Services Task Force (USPSTF) does not recommend universal screening in asymptomatic adults, concluding in its 2021 evidence review that the data are insufficient to assess benefits and harms of screening in the general population 10. Targeted testing in symptomatic or high-risk individuals remains the standard.

How Vitamin D Deficiency Is Diagnosed

The gold-standard test is the serum 25-hydroxyvitamin D (25(OH)D) assay, which reflects total body stores from both dietary intake and cutaneous synthesis. It is a simple venous blood draw with no fasting requirement.

Interpreting results. The Endocrine Society's 2011 guideline defines deficiency as a 25(OH)D level below 20 ng/mL (50 nmol/L) and insufficiency as 21 to 29 ng/mL 9. The Institute of Medicine (now National Academies) uses a lower threshold, considering 20 ng/mL sufficient for bone health in 97.5% of the population 11. Most clinicians treating symptomatic patients target a level above 30 ng/mL.

Clinicians may also order:

• Serum calcium and phosphorus to assess for secondary hyperparathyroidism or hypocalcemia.
• Intact parathyroid hormone (PTH). A PTH above 65 pg/mL alongside low 25(OH)D confirms secondary hyperparathyroidism, which drives bone resorption.
• Alkaline phosphatase. Elevated levels can indicate osteomalacia.
• 24-hour urine calcium if toxicity or granulomatous disease is suspected.

A DEXA (dual-energy X-ray absorptiometry) scan may be appropriate in patients with confirmed deficiency and fragility fracture risk. The WHO defines osteoporosis as a T-score at or below -2.5, and vitamin D repletion is a prerequisite before initiating bisphosphonate therapy 12.

Treatment: How Deficiency Is Corrected

The Endocrine Society's guideline recommends the following protocol for adults with confirmed deficiency (25(OH)D below 20 ng/mL) 9:

Loading phase: Cholecalciferol (vitamin D3) 50,000 IU once weekly for 6 to 8 weeks.

Maintenance phase: 1,500 to 2,000 IU daily thereafter.

Obese patients (BMI >30) and those on medications that accelerate vitamin D catabolism may require two to three times these doses. The guideline suggests 6,000 to 10,000 IU daily during loading, followed by 3,000 to 6,000 IU daily for maintenance, in these populations.

Cholecalciferol (D3) is preferred over ergocalciferol (D2). A meta-analysis of seven RCTs published in the American Journal of Clinical Nutrition found that D3 was approximately 87% more potent than D2 in raising and maintaining serum 25(OH)D levels 13.

For patients with malabsorption, intramuscular cholecalciferol (300,000 IU as a single injection) or calcifediol (25-hydroxyvitamin D3, marketed as Rayaldee) may be used because calcifediol bypasses hepatic hydroxylation and is better absorbed from a compromised gut 14.

Monitoring. Recheck 25(OH)D eight to twelve weeks after starting therapy. The goal is a level between 30 and 50 ng/mL. Once achieved, switch to maintenance dosing and recheck annually or semi-annually.

Dr. JoAnn Manson, professor of medicine at Harvard Medical School and principal investigator of the VITAL trial (N=25,871), noted: "For the general population without deficiency, high-dose supplementation has not reduced cardiovascular events or cancer incidence, reinforcing the importance of identifying and treating true deficiency rather than blanket supplementation" 15.

Vitamin D and Bone Health: The Core Clinical Concern

Severe, prolonged deficiency causes osteomalacia in adults and rickets in children. Both diseases result from inadequate mineralization of osteoid (newly formed bone matrix).

Osteomalacia produces diffuse bone pain, proximal muscle weakness, and a waddling gait. X-rays may reveal pseudofractures (Looser zones), typically seen at the medial femoral neck, pubic rami, or lateral scapular borders. A bone biopsy showing increased osteoid thickness and defective mineralization is the definitive diagnostic method, though it is rarely performed when the clinical and biochemical picture is clear.

The relationship between vitamin D and fracture prevention has been studied extensively. A patient-level meta-analysis of 11 RCTs (N=31,022) found that supplementation with 800 IU or more of vitamin D daily reduced hip fractures by 30% (RR 0.70; 95% CI 0.58 to 0.86) and any non-vertebral fracture by 14% in adults over 65 16. Lower doses showed no benefit. Calcium co-supplementation strengthened the effect.

These data informed the Endocrine Society's recommendation that adults aged 50 and older at risk for falls and fractures should maintain 25(OH)D levels above 30 ng/mL.

Vitamin D and Mood: What the Evidence Shows

Observational studies consistently link low 25(OH)D to higher rates of depression. A meta-analysis of 14 studies (N=31,424) found that participants in the lowest tertile of vitamin D had a 31% higher odds of depression compared to the highest tertile (OR 1.31; 95% CI 1.00 to 1.71) 17. The vitamin D receptor is expressed in prefrontal cortex, hippocampus, and amygdala neurons, suggesting a plausible biological mechanism through regulation of serotonin synthesis.

Interventional data are mixed. A 2020 meta-analysis of 25 RCTs (N=7,534) in the Journal of Affective Disorders reported a small but statistically significant improvement in depressive symptoms with vitamin D supplementation (standardized mean difference -0.28; 95% CI -0.39 to -0.17), with the strongest effect in studies that enrolled participants with baseline deficiency 18.

The clinical takeaway: vitamin D supplementation may help mood in patients who are genuinely deficient, but it is not a substitute for antidepressant therapy or psychotherapy in moderate-to-severe depression.

Special Populations at Higher Risk

Certain groups deserve proactive screening rather than waiting for symptoms to develop.

Pregnant women. Maternal vitamin D deficiency has been associated with preeclampsia, gestational diabetes, and small-for-gestational-age birth. The American College of Obstetricians and Gynecologists (ACOG) recommends 600 IU daily during pregnancy, with higher doses (1,000 to 2,000 IU) considered when deficiency is confirmed 19.

Older adults in long-term care. Institutionalized adults have negligible sun exposure. Studies of nursing home populations find deficiency prevalence exceeding 60%. The American Geriatrics Society recommends at least 1,000 IU daily plus calcium for fall and fracture prevention in this group.

Patients on chronic glucocorticoids. Prednisone doses of 7.5 mg/day or higher accelerate 24-hydroxylase activity, depleting active vitamin D metabolites. The American College of Rheumatology recommends 800 to 1,000 IU daily with calcium co-supplementation for anyone expected to take glucocorticoids for three months or longer 20.

Post-bariatric surgery patients. The American Association of Clinical Endocrinology (AACE) recommends lifelong monitoring every 6 to 12 months with typical maintenance doses of 3,000 IU daily, titrated to 25(OH)D levels above 30 ng/mL 7.

Food Sources and Practical Supplementation Tips

Few foods naturally contain meaningful amounts of vitamin D. Wild-caught salmon provides roughly 600 to 1,000 IU per 3.5-ounce serving. Farmed salmon contains only 100 to 250 IU. Fortified milk supplies approximately 100 IU per 8-ounce glass, and a large egg yolk contains about 40 IU 4.

For supplementation, absorption improves by 50% when vitamin D3 is taken with a fat-containing meal, based on a crossover study of 17 healthy adults 21. Gummy formulations and liquid drops are alternatives for patients who have difficulty swallowing capsules.

Toxicity from supplementation is rare below 10,000 IU/day. When it occurs, the mechanism is hypercalcemia rather than direct vitamin D toxicity. Symptoms include nausea, polyuria, kidney stones, and confusion. The Endocrine Society's upper safety limit is 10,000 IU/day for adults, while the Institute of Medicine sets a more conservative tolerable upper intake of 4,000 IU/day for the general population.

Patients taking thiazide diuretics should have serum calcium monitored when starting vitamin D, because thiazides reduce renal calcium excretion and the combination can precipitate hypercalcemia.

The Bottom Line

Request a 25(OH)D blood test if you have persistent fatigue, bone pain, muscle weakness, recurrent infections, or belong to a high-risk group (BMI >30, dark skin, limited sun exposure, malabsorption history, age over 65). Confirmed deficiency (below 20 ng/mL) responds to 50,000 IU of cholecalciferol weekly for 6 to 8 weeks, followed by 1,500 to 2,000 IU daily maintenance, with a recheck at 8 to 12 weeks targeting a level above 30 ng/mL 9.